Marco Minoia

Senior Clinical Project Manager at 1MED SA
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Lugano, Ticino, Switzerland, CH
Languages
  • Italian Native or bilingual proficiency
  • French Professional working proficiency
  • Spanish Limited working proficiency
  • English Full professional proficiency
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • 1MED SA
    • Switzerland
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Senior Clinical Project Manager
      • Sep 2022 - Present

    • Clinical Project Manager
      • Jun 2021 - Present

  • STALICLA
    • Switzerland
    • Biotechnology Research
    • 1 - 100 Employee
    • Clinical Project Manager
      • Dec 2020 - Jun 2021

  • Abich - Lifeanalytics Cosmetics & MD
    • Italy
    • Personal Care Product Manufacturing
    • 1 - 100 Employee
    • Project Manager
      • May 2019 - Dec 2020

  • Enantis
    • Czechia
    • Biotechnology Research
    • 1 - 100 Employee
    • Project Manager
      • 2018 - Apr 2019

  • Tampere University
    • Finland
    • Higher Education
    • 700 & Above Employee
    • Project Manager
      • 2017 - 2018

  • C1 Consulting
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Consultant
      • 2016 - 2017

  • CHARON Biotech
    • Copenhagen Area, Capital Region, Denmark
    • Co Founder
      • Sep 2015 - Dec 2016

  • DuPont
    • United States
    • Manufacturing
    • 700 & Above Employee
    • Strategy and innovation Internship
      • Feb 2015 - Jul 2015

      My aim is to evaluate the potential for personalised nutrition and to propose where and how it can be successful, providing examples of relevant opportunities and a roadmap describing what needs to be done by DuPont to succeed. My aim is to evaluate the potential for personalised nutrition and to propose where and how it can be successful, providing examples of relevant opportunities and a roadmap describing what needs to be done by DuPont to succeed.

  • Københavns Universitet - University of Copenhagen
    • Denmark
    • Research
    • 700 & Above Employee
    • Postdoc
      • May 2012 - Aug 2014

      Inhibition of horizontal gene transfer as a tool for improving antibiotic therapy. Inhibition of horizontal gene transfer as a tool for improving antibiotic therapy.

  • Georgia Institute of Technology
    • United States
    • Higher Education
    • 700 & Above Employee
    • Postdoc
      • Mar 2011 - Apr 2012

      Natural metabolic pathways, soil bacteria and plant allelopathy: an ecological link between biodegradation and toxicity. Natural metabolic pathways, soil bacteria and plant allelopathy: an ecological link between biodegradation and toxicity.

  • University of Lausanne - UNIL
    • Switzerland
    • Research Services
    • 700 & Above Employee
    • Ph.D
      • 2005 - 2011

      Horizontal gene transfer of mobile genetic elements Horizontal gene transfer of mobile genetic elements

Education

  • Copenhagen Business School
    Master's Degree, MSc in Business Administration and Bioentrepreneurship
    2014 - 2015
  • University of Lausanne - UNIL
    PhD in Molecular Microbiology, Molecular Microbiology, Biochemistry
    2005 - 2011
  • Università degli Studi di Milano
    MSc in Biotechnology, Genetic, Biochemistry, Molecular Biology, Microbiology, Plant Physiology
    1998 - 2004

Community

You need to have a working account to view this content. Click here to join now